Cerebral Vasospasm following Haemorrhagic Stroke

Schoenberg B S Schulte B. P. M. Cerebrovascular disease: Epidemiology and geopathology. In: Vinken P J Bruyn G W Klawans H L eds. Handbook of clinical neurology, Volume 53 (revised series 9). Vascular diseases, Part 1. Amsterdam: Elsevier, 1988: 1–26.

Kase C S Mohr J. P. General features of intracerebral hemorrhage. In: Barnett H J M Stein B M Mohr J P Yatsu F M eds. Stroke. Pathophysiology, diagnosis and management, Volume 1. New York: Churchill Livingstone, 1986: 497–523.

Heros R C Zervas N T Varsos V. Cerebral vasospasm after subarachnoid hemorrhage. An update. Ann Neurol 1983; 14: 599–608.

Chyatte D. Sundt J M Jr. Cerebral vasospasm after subarachnoid hemorrhage. Mayo Clin Proc 1984; 59: 498–505.

Kristler J P Crowell R M David K R . The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan. A prospective study. Neurology 1983; 33: 424–36.

Mizukami M. Takemae T. Tazawa T. . Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture. Neurosurgery 1980; 7: 583–86.

Konishi Y. Maemura E. Sato E. Hara M. Takeuchi K. A therapy against vasospasm after subarachnoid haemorrhage: Clinical experience of balloon angioplasty. Neurol Res 1990; 12: 103–105.

Brothers M F Holgate R. C. Intracranial angioplasty for treatment of vasospasm after subarachnoid hemorrhage: Technique and modifications to improve branch access. Am J Neuroradiol 1990; 11: 239–47.

Higashida R T Halbach V V Dormandy B. Bell J. Brant-Zewadski M. Hieshima G. B. New microballoon device for transluminal angioplasty of intracranial vasospasm. Am J Neuroradiol 1990; 11: 233–38.

Hughes J T Schianchi P. M. Cerebral arterial spasm. A histological study of necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978; 48: 515–25.

Grady P A Blaumanis O R Nelson E. R. Morphology and flow dynamics of focal arterial constriction. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 107–12.

Nelson E. Geitz S D Rennels M R Forbes M S Kawamura J. Scanning transmission electron microscopic studies of arterial endothelium following experimental vascular occlusion. In: Cervos-Navarro J. Betz E. Mistokos F. Willenweber R. eds. The cerebral vessel wall. New York: Raven Press, 1976: 33–39.

Sasaki T. Kassell N F Yamashita M. Fujiwara S. Disturbances of blood–brain barrier and cerebral arterial permeability following experimental subarachnoid hemorrhage. Proceedings XIIth Annual Meeting of the Society of Neurosurgical Anesthesia and Neurologic Supportive Care, 1984: 20–22.

Fein J M Flor W J Cohan S L Parkhurst J. Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries. J Neurosurg 1974; 41: 49–58.

Alksne J F Smith R. W. Experimental models of spasm. Clin Neurosurg 1977; 24: 216–27.

Simeone F A Ryan K G Cotter J. R. Prolonged experimental cerebral vasospasm. J Neurosurg 1968; 29: 357–66.

Tanabe Y. Sakata K. Yamada H. Ito T. Takada M. Cerebral vasospasm and ultrastructure changes in cerebral arterial wall. J Neurosurg 1978; 49: 229–38.

Joris I. Majno G. Endothelial changes induced by arterial spasm. Am J Pathol 1981; 102: 346–58.

Mizukami M. Kin H. Araki G. Mihara H. Yoshida Y. Is angiographic spasm real spasm? Acta Neurochir 1976; 34: 247–59.

Smith R R Clower B R Peeler D F Jr Yoshioka J. The angiopathy of subarachnoid hemorrhage: Angiographic and morphologic correlates. Stroke 1983; 14: 240–45.

Clower B R Haining J L Smith R. R. Pathophysiological changes in the cerebral artery after subarachnoid hemorrhage. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 124–31.

Tani E. Yamagata S. Ito Y. Intercellular granules and vesicles in prolonged cerebral vasospasm. J Neurosurg 1978; 48: 179–89.

Hoshi T. Shimizu T. Kito K. . Immunological study of late cerebral immunoglobulins, C3 and fibrinogen in cerebral arterial walls by immunofluorescence method. Neurol Med Chir (Tokyo) 1984; 24: 647–54.

Mayberg M R Hauser O W Sundt T M Jr. Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage. J Neurosurg 1978; 48: 49–57.

Peerless S J Kendall M. J. Cerebral vasospasm. Experimental cerebral vasospasm. In: Whisnant J P Sandok B A eds. Proceedings of the Ninth Princeton Conference on Cerebral Vascular Disease. New York: Grune & Stratton, 1975: 49–58.

Fraser R A R Stein M M Barrett R E Pool J. L. Noradrenergic mediation of experimental cerebrovascular spasm. Stroke 1970; 1: 356–62.

Owman C. Edvinsson L. Sahlin C. Svendgaard N. A. Transmitter changes in perivascular sympathetic nerves after experimental subarachnoid hemorrhage. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 279–83.

Yoshioka J. Clower B R Smith R. R. The angiopathy of subarachnoid hemorrhage. I. Role of vessel wall catecholamines. Stroke 1984; 15: 288–94.

Lobato R D Marin J. Salaices M. Burgos J. Rivilla F. Garcia A. G. Effect of experimental subarachnoid hemorrhage on the adrenergic innervation of cerebral arteries. J Neurosurg 1980; 53: 477–79.

Lobato R D Marin J. Salaices M. Rivilla F. Burgos J. Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage. J Neurosurg 1980; 53: 480–85.

Smith R R Clower B R Grotendorst G M . Arterial wall changes in early human vasospasm. Neurosurgery 1985; 16: 171–76.

Ecker A. Riemenschneider P. A. Arteriographic demonstrate of spasm of the intracranial arteries with special reference to saccular arterial aneurysms. J Neurosurg 1951; 8: 660–67.

Harada T. Suzuki Y. Satoh S. . Blood component induction of cerebral vasospasm. Neurosurgery 1990; 27: 252–55.

Nozaki K. Okamoto S. Yanamoto H. Kikuchi H. Red blood cells are essential for late vasospasm following experimentally induced subarachnoid haemorrhage in dogs. Neurol Med Chir (Tokyo) 1990; 30: 10–15.

Fisher C M Kistler J P David J. M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1–9.

Mizukami M. Takemae T. Kin H. Kawase T. Araki G. Computed tomography of ruptured intracranial aneurysm in acute stage-relationship between vasospasm and high density on CT scan. Brain Nerve (Tokyo) 1978; 30: 861–66.

Mizukami M. Takemae T. Tazawa T. Kawase T. Matsuzaki T. Value of computed tomography in the prediction of cerebral vasospasm after aneurysmal rupture. Neurosurgery 1980; 7: 583–86.

Symon L. Bell B A Kendall B. Relationship between effused blood and clinical course and prognosis in aneurysmal subarachnoid hemorrhage: A preliminary computerized tomography scan study. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 409–11.

Saito I. Sano K. Vasospasm following rupture of cerebral aneurysm. Neurol Med Chir (Tokyo) 1979; 19: 103–107.

Suzuki J. Komatsu S. Sato T. Sakurai Y. Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid hemorrhage. Acta Neurochir 1980; 55: 63–70.

Kistler J P Crowell R M Davis K R . The relationship of cerebral vasospasm to the extent and reaction of subarachnoid blood visualized by CT scan: A prospective study. Neurology 1983; 33: 424–36.

Kagstrom E. Palma L. Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage. Acta Neurol Scand 1972; 48: 257.

Schisano G. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage. Surg Neurol 1978; 10: 217–22.

Kassell N F Torner J C Adams H. P. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. J Neurosurg 1984; 61: 225–30.

Saito I. Ueda Y. Sano K. Significance of vasospasm in the treatment of ruptured aneurysms. J Neurosurg 1977; 47: 412–29.

Sano K. Saito I. Timing and indication of surgery for ruptured intracranial aneurysms with regard to cerebral vasospasm. Acta Neurochir 1978; 41: 49–60.

Suzuki J. Yoshimoto T. Onuma T. Early operations for ruptured intracranial aneurysms–study of 31 cases operated on within first four days after ruptured aneurysm. Neurol Med Chir (Tokyo) 1978; 18: 83–89.

Sasaki J. Asano T. Takakura K. Sano K. Kassell N. F. Nature of the vasoactive substance in CSF from patients with subarachnoid hemorrhage. J Neurosurg 1984; 60: 1186–91.

Nielsen K C Owman C. Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res 1971; 27: 33–42.

Allen G S Henderson L M Chou S N French L. A. Cerebral arterial spasm. Part 1: In vitro contraction of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg 1974; 40: 433–41.

Allen G S Gross C. J. Cerebral arterial spasm. Part 7: In vitro effects of alpha adrenergic agents on canine arteries from six anatomical sites and six blocking agents on serotonin-induced contractions of the canine basilar artery. Surg Neurol 1976; 6: 63–70.

Zervas N T Lavyne M H Negoro M. Neurotransmitters and the normal and ischemic cerebral circulation. N Engl J Med 1975; 293: 812–16.

Toda N. Influence of dopamine and norepinephrine on isolated cerebral arteries of the dog. Br J Pharmacol 1976; 58: 121–26.

Toda N. Alpha adrenergic receptor subtype in human, monkey and dog cerebral arteries. J Pharmacol Exp Ther 1983; 226: 861–68.

Raynor R B McMurtry J G Pool J. L. Cerebrovascular effects of topically applied serotonin in the cat. Neurology 1961; 11: 190–95.

Kapp J. Mahaley M S Odom G. L. Cerebral arterial spasm. Part 2. Experimental evaluation of mechanical and humoral factors in pathogenesis. J Neurosurg 1968; 29: 339–49.

White R P Heaton J A Denton I. C. Pharmacological comparison of prostaglandin2 alpha, serotonin and norepinephrine on cerebrovascular tone of monkey. Eur J Pharmacol 1971; 15: 300–309.

Allen G S Gold L H A Chou S N French L. A. Cerebral arterial spasm. Part 3: In-vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine. J Neurosurg 1974; 40: 451–58.

White R P Hagen A A Morgan H. Dawson W N Robertson J. T. Experimental study on the genesis of cerebral vasospasm. Stroke 1975; 6: 52–57.

Miyaoka M. Nonaka T. Watanabe H. Chigasaki H. Ishii S. Etiology and treatment of prolonged vasospasm: Experimental and clinical studies. Neurol Med Chir (Tokyo) 1976; 16: 103–14.

Osaka K. Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurg 1977; 47: 403–11.

Sonobe M. Suzuki J. Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir 1978; 44: 97–106.

Ozaki N. Mullan S. Possible role of the erythrocyte in causing prolonged cerebral vasospasm. J Neurosurg 1979; 51: 773–78.

Tanishima T. Cerebral vasospasm: Contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg 1980; 53: 787–93.

Wellum G R Irvine T W Zervas N. T. Cerebral vasoactivity of heme proteins in vitro: Some mechanistic considerations. J Neurosurg 1982; 56: 777–83.

White R P Chapleau C E Dugdale M. Robertson J. T. Cerebral arterial contractions induced by human and bovine thrombin. Stroke 1980; 11: 363–68.

Ito M. Experimental vasospasms–significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine. Neurol Med Chir (Tokyo) 1980; 20: 225–36.

Forster C. Mohan J. Whalley E. T. Interaction of fibrin degradation products and 5-hydroxytryptamine on various vascular smooth muscle preparations: Possible role in cerebral vasospasm. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980; 186–89.

Handa J. Yoneda S. Matsuda M. Handa H. Effects of prostaglandins A, E1, E2 and F2 alpha on the basilar artery of cats. Surg Neurol 1974; 2: 251–55.

Kapp J P Robertson J R White R. P. Spasmogenic qualities of prostaglandin F2 alpha in the cat. J Neurosurg 1976; 44: 173–75.

Morgan H. White R P Pennink M. Robertson J. T. Prostaglandins and experimental cerebral vasospasm. Surg Forum 1972; 23: 447–48.

Yamamoto Y L Feindel W. Wolfe L S Katoh H. Hodge C. P. Experimental vasoconstriction of cerebral arteries by prostaglandins. J Neurosurg 1972; 37: 385–97.

Rosenblum W. I. Effects of prostaglandins on cerebral blood vessels: Interaction with vasoactive amines. Neurology 1975; 25: 1169–71.

Asano T. Sasaki T. Ochiai C. Takakura K. In vitro evaluation of the inhibitory action of PGI2 to vasoconstrictions induced by various prostaglandins, serotonin and hemoglobin using the canine basilar artery. Neurol Med Chir (Tokyo) 1982; 22: 507–12.

Ellis E F Nies A S Oates J. A. Cerebral arterial smooth muscle contraction by thromboxane A2. Stroke 1977; 8: 480–82.

Toda N. Mechanism of action of carbocyclic thromboxane A2 and its interaction with prostaglandin I2 and verapamil in isolated arteries. Circ Res 1982; 51: 675–82.

Sasaki T. Kassell N F Torner J C Maixner W. Turner D. Pharmacological comparison of isolated monkey and dog cerebral arteries. Stroke 1985; 16: 482–89.

Von Holst H. Granstrom E. Hammarstrom S. Samuelsson B. Steiner L. Effect of leucotriene C4, D4, prostacyclin and thromboxane A2 on isolated human cerebral arteries. Acta Neurochir 1982; 62: 177–85.

Sasaki T. Wakai S. Asano T. Watanabe T. Kirino T. Sano K. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 1981; 54: 357–65.

Sasaki T. Asano T. Sano K. Cerebral vasospasm and free radical reactions. Neurol Med Chir (Tokyo) 1980; 20: 145–53.

Koide T. Noda Y. Hata S. Sugioka K. Kobayashi S. Nakano M. Contraction of the canine basilar artery following lineoleic, arachidonic, 13-hydroperoxylineoleic, or 15-hydroperoxyarachidonic acid (41294). Proc Soc Exp Biol Med 1981; 168: 399–402.

Asano T. Tanishima T. Sasaki T. Sano K. Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 190–201.

Sano K. Cerebral vasospasm and aneurysm surgery. Clin Neurosurg 1983; 30: 13–58.

Toda N. Responsiveness to potassium and calcium ions of isolated cerebral arteries. Am J Physiol 1974; 227: 1206–11.

Wilkins R H Levitt P. Potassium and the pathogenesis of cerebral arterial spasm in dog and man. J Neurosurg 1971; 35: 45–50.

Shiguma M. Change in the ionic environment of cerebral arteries after subarachnoid hemorrhage. Especially of potassium ion concentration in subarachnoid hematoma and its role in cerebral vasospasm. Neurol Med Chir (Tokyo) 1982; 22: 805–12.

Suzuki H. Sato S. Suzuki Y. Takekoshi K. Ishihara N. Shimoda S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 1990; 81: 553–54.

Alafaci C. Salpiertro F M Iacopino D G Edvinsson L. Tomasello F. Endothelin: An endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm. Ital Neurol Sci 1991; 12: 55–58.

Yamaura I. Tani E. Maeda Y. Minami N. Shindo H. Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 1992; 76: 99–105.

Asano T. Ikegaki I. Satoh S. . Endothelin: A potential modulator of cerebral vasospasm. Eur J Pharmacol 1990; 190: 365–72.

Ide K. Yamakawa K. Nakagomi T. . The role of endothelin in the pathogenesis of vasospasm following subarachnoid hemorrhage. Neurol Res 1989; 11: 101–104.

Caner H. Oruckaptan H. Bolay H. . The role of lipid peroxidation in the genesis of vasospasm secondary to subarachnoid hemorrhage. Kobe J Med Sci 1991; 37: 13–20.

Macdonald R L Weir B K Runzer T D . Etiology of cerebral vasospasm in primates. J Neurosurg 1991; 75: 415–24.

Iwai R. Kamiyama K. Nagahori T. Ohtsuji T. Endo S. Takaku A. Relation of supersensitivity to cerebral vasospasm induced by oxyhaemoglobin. Neurol Res 1988; 10: 169–74.

Edvinsson L. Alafaci C. Delgado T. . Neuropeptide Y and vasoactive intestinal peptide in experimental subarachnoid hemorrhage: Immunocytochemistry, radioimmunoassay and pharmacology. Acta Neurol Scand 1991; 83: 103–109.

Juul R. Edvinsson L. Fredriksen T A Ekman R. Brubakk A O Gisvold S. E. Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid hemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm. Acta Neurochir 1990; 107: 75–81.

Abel P W Han C. Noe B D McDonald J. K. Neuropeptide Y: Vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Res 1988; 463: 250–58.

Matsui T. Takuwa Y. Johshita H. Yamashita K. Asano T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab 1991; 11: 143–49.

Arienta C. Balbi S. Caroli M. Fumagalli G. Depletion of calcitonin gene-related peptide in perivascular nerves during acute phase of posthemorrhagic vasospasm in the rabbit. Brain Res Bull 1991; 27: 605–609.

Farrar J K Jr. Chronic cerebral arterial spasm: The role of intracranial pressure. J Neurosurg 1975; 43: 408–17.

Johnston I H Rowan J O Haper A M Jennett W. B. Raised intracranial pressure and cerebral blood flow. J Neurol Neurosurg Psychiatry 1972; 35: 285–96.

Farrar J K Jr Roach M. R. The effects of increased intracranial pressure on flow through major cerebral arteries in vitro. Stroke 1973; vmr-4: 795–806.

Beks J. W. F. Cerebral vasospasm and increased intracranial pressure. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 412–13.

Hart M. N. Morphometry of brain parenchymal vessels following subarachnoid hemorrhage. Stroke 1980; 11: 653–55.

Baumbach G L Heistad D. D. Effect of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ Res 1983; 52: 527–33.

Grubb R L Jr Raichle M E Eichlins J O Gado M. H. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow and oxygen utilization in humans. J Neurosurg 1977; 46: 446–53.

Millikan C. H. Cerebral vasospasm ruptured intracranial aneurysm. Arch Neurol 1975; 32: 433–49.

Kassell N F Sasaki T. Colohan A R T Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562–72.

Artiola I. Fortuny L. Adams C. B. T. Predicting outcome in patients with intracranial aneurysms with the help of microsurgery. J Neurol Neurosurg Psychiatry 1981; 44: 615–20.

Richardson J. T. E. Arterial spasm and recovery from subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1976; 39: 1134–36.

Tomer J C Kassell N F Wallace R B . Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy. Report of the Cooperative Aneurysm Study. Neurosurgery 1981; 9: 505–13.

Weir B. Rothberg C. Grace M. . Relative prognostic significance of vasospasm following subarachnoid hemorrhage. Can J Neurol Sci 1975; 2: 109–14.

Ropper A H Zervas N. T. Outcome 1 year after SAH from cerebral aneurysm. Management morbidity, mortality and functional status in 122 consecutive good-risk patients. J Neurosurg 1984; 60: 909–14.

Kwak R. Niizuma H. Ohi T. . Angiographic study of cerebral vasospasm following rupture of intracranial aneurysms. I. Time of the appearances. Surg Neurol 1979; 11: 257–62.

Ohno K. Masaoka H. Suzuki R. Monma S. Matsushima Y. Symptomatic cerebral vasospasm of unusual late onset after aneurysmal rupture. Acta Neurochir 1991; 108: 163–66.

Adams H P Jr. Medical treatment of aneurysmal subarachnoid hemorrhage. In: Fisher M. ed. Medical therapy of acute stroke. New York: Marcel Dekker, 1989: 253–80.

Tomasello F. Albanese V. Picozz P. . Relation of cerebral vasospasm to operative findings of subarachnoid blood around ruptured aneurysms. Acta Neurochir 1982; 60: 55–62.

Tazawa T. Mizukami M. Kawase T. . Relationship between contrast enhancement on computed tomography and cerebral vasospasm in patients with subarachnoid hemorrhage. Neurosurgery 1983; 12: 643–48.

Black P McL. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms. Neurosurgery 1986; 18: 12–16.

Hijdra A. Van Gijn J. Stefanko S. . Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Clinicoanatomic correlations. Neurology 1986; 36: 329–33.

Fisher C M Robertson G H Ojemann R. G. Cerebral vasospasm with ruptured saccular aneurysm. The clinical manifestations. Neurosurgery 1977; 1: 245–48.

Simpson R K Jr Fischer D K Ehni B. L. Neurogenic hyperthermia in subarachnoid hemorrhage. South Med J 1989; 82: 1577–78.

Jakobsen M. Enevoldsen E. Dalager T. Spasm index in subarachnoid haemorrhage: Consquences of vasospasm upon cerebral blood flow and oxygen extraction. Acta Neurol Scand 1990; 82: 311–20.

Soucy J P McNamara D. Mohr G. Lamoureux F. Lamoureux J. Danais S. Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethyl-propyleneamine oxime (HM-PAO) tomoscintigraphy. J Nucl Med 1990; 31: 972–77.

Klingelhofer J. Dander D. Holzgraefe M. Bischoff C. Conrad B. Cerebral vasospasm evaluated by transcranial Doppler ultrasonography at different intracranial pressures. J Neurosurg 1991; 75: 752–58.

Sloan M A Haley E C Jr Kassell N F . Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 1989; 39: 1514–18.

Hassler W. Chioffi F. CO2 reactivity of cerebral vasospasm after aneurysmal subarachnoid haemorrhage. Acta Neurochir 1989; 98: 167–75.

Lindegaard K F Nornes H. Bakke S J Sortenberg W. Nakstad P. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir 1988; 42: 81–84.

Sekhar L N Wechsler L R Yonas H. Luyckx K. Obrist W. Value of transcranial Doppler examination in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1988; 22: 813–21.

Newell D W Grady M S Eskridge J M Winn H. R. Distribution of angiographic vasospasm after subarachnoid hemorrhage: Implications for diagnosis by transcranial Doppler ultrasonography. Neurosurgery 1990; 27: 574–77.

Yonas H. Sekhar L. Johnson D W Gur D. Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 1989; 24: 368–72.

Rivierez M. Landau-Ferey J. Grob R. Grosskopf D. Philippon J. Value of electroencephalogram in prediction and diagnosis of vasospasm after intracranial aneurysm rupture. Acta Neurochir 1991; 110: 17–23.

Lipschitz R. Davidson K. Strugo V. Somatosensory evoked potentials quantify clinical improvement of cerebral vasospasm after intravenous administration of nimodipine. S Afr Med J 1988; 74: 403–405.

Wilkins R. H. Attempted prevention or treatment of intracranial arterial spasm. A survey. In: Wilkins R H ed. Cerebral arterial spasm. Baltimore: Williams & Wilkins, 1980: 542–55.

Mizukami M. Kawase T. Usami T. . Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 1982; 10: 301–307.

Taneda E. Effect of early operation for ruptured aneurysms on prevention of delayed ischaemia symptoms. J Neurosurg 1982; 57: 622–28.

Inagawa T. Yamamoto M. Kamiya K. Effects of clot removal on cerebral vasospasm. J Neurosurg 1990; 72: 224–30.

Inagawa T. Kamiya K. Matsuda Y. Effects of continuous cisternal drainage on cerebral vasospasm. Acta Neurochir 1991; 112: 28–36.

Inagawa T. Effect of early operation on cerebral vasospasm. Surg Neurol 1990; 33: 239–46.

Benzel E C Kesterson L. Extracranial–intracranial bypass surgery for the management of vasospasm after subarachnoid hemorrhage. Surg Neurol 1988; 30: 231–34.

Allen G S Ahn H. S. Preziosi T J . Cerebral arterial spasm. A controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619–24.

Weir B. Calcium antagonists, cerebral ischemia and vasospasm. Can J Neurol Sci 1984; 11: 239–46.

Meldrum B. S. Calcium entry blockers and cerebral function. An introduction. In: Godfraind T. Herman A G Wellens D. eds. Calcium entry blockers in cardiovascular and cerebral dysfunctions. Boston: Martinus Nijhoff, 1984: 207–19.

Wellens D. Twenty-seven calcium entry blockers in development. A new chapter in pharmacology. In: Godfraind T. Herman A H Wellens D. eds. Calcium entry blockers in cardiovascular and cerebral dysfunctions. Boston: Martinus Nijhoff, 1984: 25–42.

Auer L. M. Acute operation and preventive nimodipine improves outcome in patients with ruptured cerebral aneurysm. Neurosurgery 1984; 15: 57–66.

Ljunggren B. Brandt L. Saveland H. . Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg 1984; 61: 864–73.

Adams H. Flamm E. Beck D. Godersky J. Pinto R. A study of nicardepine in prevention of infarction after subarachnoid hemorrhage. Stroke 1987; 18: 281A.

Seiler R W Grolimund P. Zurbrugg H. R. Evaluation of the calcium antagonist nimodipine for the prevention of ischaemia after aneurysmal subarachnoid hemorrhage. Stroke 1987; 18: 281A.

Saveland H. Ljunggren B. Brandt L. . Delayed ischemic deterioration in patients with early aneurysm operation and intravenous nimodipine. Neurosurgery 1986; 18: 146–50.

Buchheit F. Boyer P. Review of treatment of symptomatic cerebral vasospasm with nimodipine. Acta Neurochir 1988; 45 (suppl): 51–55.

Gilsbach J. M. Nimodipine in the prevention of ischaemic deficits after aneurysmal subarachnoid haemorrhage. An analysis of recent clinical studies. Acta Neurochir 1988; 45 (suppl): 41–50.

Jan M. Buchheit F. Tremoulet M. Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 1988; 23: 154–57.

Hillman J. Bynke O. Westergren H. Nimodipine evoked dilatation of cerebral arteries early during the development of late vasospasm in subarachnoid hemorrhage. Neurochirurgia 1991; 34: 157–59.

Flamm E S Adams H P Jr Beck D W . Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988; 68: 393–400.

Pasqualin A. Vollmer D G Marron J A Tsukahara T. Kassell N F Torner J. C. The effect of nicardipine on vasospasm in rabbit basilar artery after subarachnoid hemorrhage. Neurosurgery 1991; 29: 183–88.

Toda N. Kawakami M. Kodama N. Prevention by nicardipine of dog basilar artery spasm caused by oxyhemoglobin in vivo and in vitro. Eur J Pharmacol 1991; 195: 175–77.

Fujita S. Kawaguchi T. Shose Y. Urui S. Flunarizine treatment in poor-grade aneurysm patients. Acta Neurochir 1990; 103: 11–17.

Lewis P J Weir B K Nosko M G Tanabe T. Grace M. G. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 1988; 22: 492–500.

Sundt T. M. Management of ischemic complications after subarachnoid hemorrhage. J Neurosurg 1975; 43: 418–25.

Heros R C Zervas N T Negoro M. Cerebral vasospasm. Surg Neurol 1976; 5: 354–62.

Allen G. S. Cerebral arterial spasm. Part 8. The treatment of delayed arterial spasm in human beings. Surg Neurol 1976; 6: 71–80.

Flamm E S Ransohoff J. Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate. Surg Neurol 1976; 6: 223–26.

Noseworthy T W Weir B. Boisvert D. . Effect of reserpine–kanamycin treatment on chronic vasospasm after platelet enriched subarachnoid hemorrhage in primates. Neurosurgery 1984; 14: 193–97.

Otsubo H. Takemae T. Inoue T. Kobayashi S. Sugita K. Normovolaemic induced hypertension therapy for cerebral ischaemia after subarachnoid hemorrhage. Acta Neurochir 1990; 103: 18–26.

Hadeishi H. Mizuno M. Suzuki A. Yasui N. Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo) 1990; 30: 317–23.

Levy M L Giannotta S. L. Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991; 75: 27–31.

Giannotta S L McGillicuddy J E Kindt G. W. Diagnosis and treatment of postoperative cerebral vasospasm. Surg Neurol 1977; 8: 286–90.

Kassell N F Peerless S J Durward Q J . Treatment of ischemic deficit from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11: 337–43.

Pritz M B Giannotta S L Kindt G W . Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978; 3: 364–68.

Shaw M D W Foy P M Conway M. . Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage. J Neurosurg 1985; 63: 699–703.

Fukomori T. Tani E. Maeda Y. . Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm. J Neurosurg 1983; 59: 829–34.

Stanworth P A Dutton J. Paul K S Fawcett R. Wallery E. Prostacyclin: A new treatment for vasospasm associated with subarachnoid haemorrhage. Acta Neurochir 1988; 42 (suppl): 85–87.

Egeman N. Birler K. Avman N. Turker R. K. Experimental cerebral vasospasm: Resolution by iloprost. Acta Neurochir 1988; 95: 131–35.

Kassell N F Peerless S J Drake C G . Treatment ischemic deficits from cerebral vasospasm with high dose barbiturate therapy. Neurosurgery 1980; 7: 593–97.

Ohta T. Kikuchi H. Hashi K. . Nizofenone administration in the acute stage of following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study. J Neurosurg 1986; 64: 420–26.

Findlay J M Weir B K Steinke D. Tanabe T. Gordon P. Grace M. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 1988; 69: 723–35.

Findlay J M Weir B K Kanamura K. Grace M. Baughman R. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 1990; 26: 201–206.

Seifert V. Eisert W G Stolke D. Goetz C. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 1989; 25: 590–98.

Ohman J. Servo A. Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 197–201.

Zabramski J M Spetzler R F Lee K S . Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 189–96.

Findlay J M Weir B K Kassell N F Disney L B Grace M. G. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 181–88.

Mizoi K. Yoshimoto T. Fujiwara S. Sugawara T. Takahashi A. Koshu K. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: Preliminary report. Neurosurgery 1991; 28: 807–12.

Peterson J W Candia G. Spanos A J Zervas N. T. The calmodulin antagonist trifluoperazine provides mild prophylactic protection against cerebral vasospasm after subarachnoid hemorrhage, but no therapeutic value. Neurosurgery 1989; 25: 917–22.

Nozaki K. Uemura Y. Okamoto S. Kikuchi H. Mizuno N. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs. J Neurosurg 1989; 71: 558–64.

Naylor A R Robertson I J Edwards C R . Cerebral vasospasm following subarachnoid hemorrhage: Effect of calcitonin gene-related peptide on middle cerebral artery velocities using transcranial Doppler sonography. Surg Neurol 1991; 36: 278–80.

Tokiyoshi K. Ohnishi T. Nii Y. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 1991; 36: 112–18.

Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989; 20: 1021–26.

Yamakawa K. Sasaki T. Tsubaki S. Nakagomi T. Saito I. Takakura K. Effect of high-dose methyl prednisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1991; 31: 24–31.

Zuccarello M. Marsch J T Schmitt G. Woodward J. Anderson D. K. Effect of the 21–aminosteroid U-74006 F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1989; 71: 98–104.

Vollmer D G Kassell N F Hongo K. Ogawa H. Tsukahara T. Effect of the nonglucocorticoid 21-aminosteroid U-74006F in experimental cerebral vasospasm. Surg Neurol 1989; 31: 190–94.

Steinke D E Weir B K Findlay J M Tanabe T. Grace M. Krushelnycky B. W. A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 1989; 24: 179–86.

Kanamaru K. Weir B K Findlay J M Grace M. Macdonald R. L. A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model. Neurosurgery 1990; 27: 29–38.

Peterson J W Nishizawa S. Hackett J D Bun T. Teramura A. Zervas N. T. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 1990; 21: 133–37.

Handa Y. Hayashi M. Takeuchi H. Kobayashi H. Kawano H. Kabuto M. Effect of cyclosporine in the development of cerebral vasospasm in a primate model. Neurosurgery 1991; 28: 380–85.

Ryba M. Pastuszko M. Iwanska K. Bidzinski J. Dziewiecki C. Cyclosporine A prevents neurological deterioration of patients with SAH – a preliminary report. Acta Neurochir 1991; 112: 25–27.

Shigeno T. Mima T. Yanagisawa M. . Prevention of cerebral vasospasm by actinomycin D. J Neurosurg 1991; 74: 940–43.

Vollmer D G Hongo K. Ogawa H. Tsukahara T. Kassell N. F. A study of the effectiveness of the iron-chelating agent deferrioxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 1991; 8: 27–32.

Matsumura Y. Ikegawa R. Suzuki Y. . Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: The relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 1991; 49: 841–48.

Ram Z. Sadeh M. Shacked I. Sahar A. Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22: 922–27.

Vorkapic P. Bevan J A Bevan R. D. Clentiazem protects against chronic cerebral vasospasm in rabbit basilar artery. Stroke 1991; 22: 1409–13.

Satoh S. Suzuki Y. Ikegaki I. . The effects of HA1077 on the cerebral circulation after subarachnoid haemorrhage in dogs. Acta Neurochir 1991; 110: 185–88.

Minami N. Tani E. Maeda Y. Yamaura I. Fukami M. Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm. J Neurosurg 1992; 76: 111–18.

Newell D W Eskridge J M Mayberg M R Grady M S Winn H. R. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 1989; 71: 654–60.

Higashida R T Halbach V V Cahan L D . Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989; 71: 648–53.

Bracard S. Picard L. Marchal J C . Role of angioplasty in the treatment of symptomatic vascular spasm occurring in the post-operative course of intracranial ruptured aneurysms. J Neuroradiol 1990; 17: 6–19.

Konishi Y. Maemura E. Sato E. Hara M. Takeuchi K. A therapy against vasospasm after subarachnoid haemorrhage: Clinical experience of balloon angioplasty. Neurol Res 1990; 12: 103–105.

Brothers M F Holgate R. C. Intracranial angioplasty for treatment of vasospasm after subarachnoid hemorrhage: Technique and modifications to improve branch access. Am J Neuroradiol 1990; 11: 239–47.

Higashida R T Halbach V V Dormandy B. Bell J. Brant-Zawadzki M. Hieshima G. B. New microballoon device for transluminal angioplasty of intracranial arterial vasospasm. Am J Neuroradiol 1990; 11: 233–38.

Grimes C. M. Cerebral balloon angioplasty for treatment of vasospasm after subarachnoid hemorrhage. Heart Lung 1991; 20: 431–35.

Linskey M E Horton J A Rao G R Yonas H. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Case report. J Neurosurg 1991; 74: 985–90.

Macfarlane R. Teramura A. Owen C J . Treatment of vasospasm with a 480-nm pulsed dye laser. J Neurosurg 1991; 74: 613–22.

Teramura A. Macfarlane R. Owen C J . Application of the 1-microsecond pulsed-dye laser to the treatment of experimental cerebral vasospasm. J Neurosurg 1991; 75: 271–76.